Premium
Retinoids: novel immunomodulators and tumour‐suppressive agents?
Author(s) -
Carratù MR,
Marasco C,
Mangialardi G,
Vacca A
Publication year - 2012
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.2012.02031.x
Subject(s) - retinoid , medicine , immune system , systemic lupus erythematosus , immunology , cancer research , pharmacology , biology , disease , retinoic acid , cell culture , genetics
Retinoids play important roles in the transcriptional activity of normal, degenerative and tumour cells. Retinoid analogues may be promising therapeutic agents for the treatment of immune disorders as different as type I diabetes and systemic lupus erythematosus. In addition, the use of retinoids in cancer treatment has progressed significantly in the last two decades; thus, numerous retinoid compounds have been synthesized and tested. In this paper, the actual or potential use of retinoids as immunomodulators or tumour‐suppressive agents is discussed.